Novartis Access: Medicines to treat chronic diseases in lower-income countries

Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low and middle income countries.

Videos from this campaign

Content from this campaign

Health & Healthcare

Novartis Receives FDA Approval for Egaten® for the Treatment of Fascioliasis, a Neglected Tropical Disease
Novartis announced today that the US Food and Drug Administration (FDA) has approved Egaten® (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This makes Egaten the only FDA-approved drug for people with this disease and is expected to facilitate broader access to this important drug not only in the US, but also in affected countries worldwide.

Health & Healthcare

Sandoz Selects Three Finalists for Healthcare Access Challenge (Sandoz HACk) From Over 400 Global Entries
Sandoz, a Novartis division, today announced the three finalists for the second Sandoz Healthcare Access Challenge (HACk).

The three shortlisted entrants are from Uganda, the US and the Netherlands, respectively. They propose novel ways of leveraging digital technology, including artificial intelligence (AI), mobile apps and digital therapeutics, to connect patients with caregivers, medicines and information and address local healthcare access challenges.

Health & Healthcare

Novartis Access Launches in Latin America
Novartis has signed an agreement with the municipality and the Patronato of Santa Tecla in El Salvador to distribute the Novartis Access portfolio to low-income patients with non-communicable diseases (NCDs) in this community. Beyond medications, the collaboration will also help train health professionals in NCD diagnosis and treatment, and promote education and awareness in the local community.

Health & Healthcare

Sandoz Healthcare Access Challenge (HACk) Returns, Seeking Digital Solutions to Local Healthcare Access Challenges
Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The Sandoz HACk is a global competition that invites entrepreneurs and innovators in the field of digital technology to submit inspirational ideas with the potential to complement – or even positively disrupt – established approaches to driving access to healthcare. Sandoz HACk opens for entries today (October 4), closing on November 30, 2018.

Health & Healthcare

GARDP and Novartis Announce Partnership to Reduce Child Deaths From Drug-resistant Infections
The Global Antibiotic Research & Development Partnership (GARDP) and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.

Health & Healthcare

Novartis, ASCP and ACS Join Forces to Fight Cancer in Ethiopia, Uganda and Tanzania

Health & Healthcare

Punjab Province in Pakistan Signs Agreement With Novartis Access Against Chronic Diseases
Today, the provincial government of Punjab in Pakistan signed a Memorandum of Understanding with Novartis to roll out Novartis Access. Poor patients in the province of Punjab will soon have free access to high-quality medicines from the Novartis Access portfolio targeting four key noncommunicable disease areas (NCDs): cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The agreement also includes the implementation of innovative software to track and monitor individual patient access and adherence.

Health & Healthcare

Novartis Access and Government of Cameroon Sign Memorandum of Understanding to Fight Chronic Diseases
Novartis has reached an agreement with Cameroon to supply medicines against chronic diseases for the poorest populations. The collaboration also includes capacity-building activities with the Cameroon Baptist Convention Health Services (CBCHS) on community awareness.

Health & Healthcare

Living With Hypertension in Cameroon When You Live on Only a Few Dollars a Day
This month like the previous ones, Alvine Nyintché is visiting the Etoug-Ebe Baptist Hospital in Yaounde. Aged 50, Alvine has been diagnosed with high blood pressure seven years ago.

Health & Healthcare

Novartis Access and Government of Uganda Sign Memorandum of Understanding
Novartis and the Ministry of Health of Uganda have signed a Memorandum of Understanding to implement Novartis Access in Uganda. Uganda becomes the fifth country to launch the Novartis Access program. Novartis Access medicines will be made available to patients in public health facilities through the National Medical Stores and through faith-based health services. The program will also cover capacity-building activities, including NCD prevention, diagnosis and treatment.
Novartis logo

More from Novartis

  1. Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US
    Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...

  2. Novartis US Foundation
    Initiatives summarizing efforts from the Novartis US Foundation.

  3. Novartis COVID-19 Trials
    Novartis clinical trial efforts in COVID-19 R&D.

  4. Novartis US Foundation COVID-19 Response
    In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...

  5. Novartis – science based innovation for better patient outcomes
    Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

  6. Novartis Foundation Leprosy Elimination Initiative
    The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...

  7. Novartis Access: Medicines to treat chronic diseases in lower-income countries
    Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...

  8. The Novartis Malaria Initiative
    For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...